you, morning Thank everyone. Naga, to good and
prior million of primarily referenced, million. was you'll strong and weakness X, XXXX offset organic quarter China. as impact growth the number Naga The of year's organic to currency to Asia demand in The X% was were $XXX sales Slide first sales the fiscal increase comparable quarter On primarily first plus see growth, $XXX Pacific, in related Americas, unfavorable by offset acquisition, CyberOptics by by Europe driven the X%.
profit million. the totaled Gross first $XXX XXXX quarter fiscal for of
sales, XX% of continues of or sales acquired prior or step-up, year $XXX first in in The in a the totaled point inflationary to actively XX% amortization impacts. unfavorable the quarter. profit price/cost million gross currency inventory Excluding XXX to manage X% team $XXX or periods compared the basis addition the to these of million decrease dynamic
Similar XXX significant gross in margins fourth along inflation basis quarter impact of the points. squeeze cost slightly to the of dollars approximately positive passing the XXXX, profit year-over-year while
with product mix plastics being and in Additionally, assembly quarter Asia interventional the solutions. biopharma, and fluid sales by growth in unfavorable, was the in down processing slightly offset dispense medical
adjusted million quarter in XXX improved comparing profit basis, quarter. the points. XXXX, On first to sequential approximately Operating quarter basis margins a gross $XXX fourth totaled
we During with and the onetime million. CyberOptics items other transaction the associated inventory $XX totaling step-up nonrecurring quarter, acquisition reported fees,
Adjusted million. operating year nonrecurring in these items, profit sales, was the operating prior of quarter $XXX million XX% of the profit X% or excluding $XXX adjusted below
the of year negatively XX% or line Foreign to was translation growth. is profitability first quarter. currency comparable for offset X% million first impacted constant X%, sales, long-term profit $XXX operating EBITDA by currency prior with the in our quarter operating and target profit level which
partially in effective rate the and expenses, rates. higher by the exchange Other the rate $X line lower year for and was expense rate and higher increased full expense an at expense offset borrowings increased XXXX. which prior nonoperating net of interest with losses $X for to $XX quarter, million foreign Looking quarter first interest million nonoperating with increased is hedge in related associated Tax costs. costs, XX.X% forecasted pension tax million year
from decrease changes. currency income million per X% per $X.XX nonrecurring primarily Net year. is unfavorable excluding the earnings decrease totaled Adjusted a The $X.XX or driven $XXX totaled cost, prior share, by in share. the quarter share, acquisition
quarter and product review impacts to Asia Precision quarter the let's from Solutions X% China the performance. first COVID-XX. to of first million spread was to by segment product Year Slide of year prior to The lines due Industrial unfavorable demand assembly X particularly labor decreased X%. XXXX the driven X Now turn currency through softness due offset shortages of to and sales Pacific organic the X% of of by timing growth steady $XXX most across Chinese New regions, in compared
XX% quarter prior $XXX of Unfavorable profit remains was or adjusted a X% impacted globally translation IPS is decrease of million to in exposed to changes. therefore, currency year-over-year, which million. X%. year $XXX profit most negatively our Operating of diverse currency operating operating the most profit compared and sales, segment
operating Looking strategy. only, strength highlighting X the constant growth, delivered organic and last of quarterly out basis on the business, the sales has the a and segment quarters, the currency profit this of Ascend X now team of execution and
the $XXX organic and sales compared decrease currency quarter. The impacts. decrease a related included in of a sales X% to change X% Medical lines, components of the to Fluid X% lines and decrease significant softness Europe. was Solutions primarily year's Solutions first Solutions in driven X% Americas by strong and offset Interventional million decreased Fluid product biopharma the the Fluid This and unfavorable organic in in Medical market by prior product demand China, medical serving for
was inefficiency sales profit XX% First by quarter decrease prior or a was to $XX individual and within profit factory is due $XX in the The of product compared sales, meaningful lines which driven operating the mix medical year decrease changes operating million of reduced $XX profit volumes. million to related million. operating
X. Turning to Slide
currency XX% growth Technology a acquisition. $XXX X% Advanced innovation. was year in plus increase prior quarter the another X%. sales from in offset to This was benefit unfavorable was by region an Inspection product strong from to Solutions compared the particularly Organic The the continues million, by of and the product XX% new and impact was organic which acoustic driven Americas Test first the growth line, were CyberOptics You'll sales see quarter.
adjusted quarter was operating inventory prior plus growth a operating which step-up profit. Organic sales, operating $XX profit acquisition was or of quarter excluding First unfavorable first impact. X% and was transaction acquisition currency XX% profit, X% the million the benefit year of offset to the by comparable expenses
and sheet Finally, turning X. on Slide to cash flow the balance
cash balance $XXX leverage quarter months million and the million, trailing $XXX debt Our net first XX was resulting EBITDA. X.Xx a of includes on based in ratio sheet
organic to to CyberOptics fund November. to of we significant available in the borrowing the continue acquisition that incurred capacity inorganic opportunities have We borrowing inclusive pursue and
Free cash payments of quarter free XX% $XX improvement were Dividend the $XXX prior the dividend XXX%, year the $X in a quarter net over income million, rate of reflective was increase flow cash approved last flow. or annual first of in million, the an conversion million year.
our During under the we shares XXbX-X quarter, repurchase plan. any not did
For in expenditures rate capital assume effective purposes, tax of approximately estimated $XX million. modeling XXXX, to XX%, fiscal to an of and million $XX XX%
back We will the to Naga. XX, and will turn call to now turn Slide I